Disaccharides generated from heparan sulphate or heparin modulate chemokine-induced T-cell adhesion to extracellular matrix

Immunology

Volumn 99, Issue 1, 2000, Pages 87-93

  Hershkoviz, R ^a   Schor, H ^a   Ariel, A ^a   Hecht, I ^a   Cohen, I R ^a   Lider, O ^a   Cahalon, L ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; HEPARAN SULFATE;

ARTICLE; CELL ACTIVATION; CELL KINETICS; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD29; CELL ADHESION; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; DISACCHARIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX; FEEDBACK; FIBRONECTINS; GROWTH INHIBITORS; HEPARIN; HEPARITIN SULFATE; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRINS; LYMPHOCYTE ACTIVATION; MACROPHAGE INFLAMMATORY PROTEIN-1; RANTES; RECEPTORS, FIBRONECTIN; RECEPTORS, LYMPHOCYTE HOMING; T-LYMPHOCYTES;

EID: 0033965058     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00931.x     Document Type: Article

References (27)

1. 1. Butcher E.C. & Picker L.J. (1996) Lymphocyte homing and homeostasis. Science 212, 60.
2. 2. Nathan C. & Sporn M. (1991) Cytokine in context. J Cell Biol 113, 981.
3. 3. Gilat D., Cahalon L., Hershkoviz R. & Lider O. (1996) Counter-interactions between tissue-infiltrating T lymphocytes, pro-inflammatory mediators, and enzymatically-modified extracellular matrix. Immunol Today 17, 16.
4. 4. Adams D.H. & Lloyd A.R. (1997) Chemokines: leucocyte recruitment and activation cytokines. Lancet 349, 490.
5. 5. Ariel A., Yavin E.J., Hershkovix R. et al. (1998) IL-2 induces T cell adherence to extracellular matrix: inhibition of adherence and migration by IL-2 peptides generated by leukocyte elastase. J Immunol 161, 2465.
6. + T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored MIP-1β and RANTES. J Immunol 153, 4899.
7. 7. Owen C.A. & Campbell E.J. (1999) The cell biology of leukocyte-mediated proteolysis. J Leuk Biol 65, 137.
8. 8. Lider O., Cahalon L., Gilat D. et al. (1995) A disaccharide that inhibits tumor necrosis factor-α is formed from the extracellular matrix by the enzyme heparanase. Proc Natl Acad Sci USA 92, 5037.
9. 9. Fridman R., Lider O., Naparstek Y., Fuks Z., Vlodavsky I. & Cohen I.R. (1986) Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix. J Cell Physiol 130, 85.
10. 10. Cahalon L., Lider O., Schor H. et al. (1997) Heparin disaccharides inhibit tumor necrosis factor-α production by macrophages and arrest immune inflammation. Int Immunol 1997 (9), 1517.
11. 11. Lindahl U. & Kjellen L. (1991) Heparin and heparan sulfate what is the difference? Thromb Haemos 66, 44.
12. 12. Toullec D., Pianetti P., Coste H., Kirilovsky J. et al. (1991) The bisindolylmaleimide GFI09203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266, 157711.
13. 13. Grimm M.C., Ben-Baruch A., Taub D.D., Howard O.M., Wang J.M. & Oppenheim J.J. (1998) Opiate inhibition of chemokine-induced chemotaxis. Ann NY Acad Sci 840, 9.
14. 14. Ben-Baruch A., Grimm M., Bengali K. et al. (1997) The differential ability of IL-8 and neutrophil-activating peptide-2 to induce attenuation of chemotaxis is mediated by their divergent capabilities to phosphorylate CXCR2 (IL-8 receptor B). J Immunol 158, 5927.
15. 15. Tanaka Y., Kimata K., Wake A. et al. (1996) Heparan sulfate proteoglycan on leukemic cells is primarily involved in integrin triggering and its mediated adhesion to endothelial cells. J Exp Med 184, 1987.
16. 16. Ihrcke N.S., Parker W., Reissner K.J. & Platt J.L. (1998) Regulation of platelet heparanase during inflammation: role of pH and proteinases. J Cell Physiol 175, 255.
17. 17. Wrenshall L.E., Cerra F.B., Carlson A., Bach F.H. & Platt J.L. (1991) Regulation of murine splenocyte responses by heparan sulfate. J Immunol 147, 455.
18. 18. Ihrecke N.S., Wrenshall L.E., Lindman B.J. & Platt J.L. (1993) Role of heparan sulfate in immune system blood vessel interactions. Immunol Today 14, 500.
19. 19. Ihrcke N.S. & Platt J.L. (1996) Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules. J Cell Physiol 168, 625.
20. 20. Rechter M., Lider O., Cahalon L. et al. (1999) A cellulose binding domain-fused recombinant human T cell chemokine CTAP-III manifests heparanase activity. Biochem Biophys Res Commun 255, 657.
21. 21. Hoogewerf A.J., Leone J.W., Reardon I.M. et al. (1995) CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes. J Biol Chem 270, 3268.
22. 22. Webb L.M., Ehrengruber M.U., Clark-Lewis I., Baggiolini M. & Rot A. (1993) Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci USA 90, 7158.
23. 23. Hoogewerf A.J., Kuschert G.S.V., Proudfoot A.E.I, et al. (1997) Glycosaminoglycans mediate cell surface oligomerization of chemokines. J Biol Chem 36, 13570.
24. 24. Bradbury M.G. & Parish C.R. (1991) Characterization of lymphocyte receptors for glycosaminoglycans. Immunology 72, 231.
25. 25. Campbell J.J., Foxman E.F. & Butcher E.C. (1997) Chemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migration. Eur J Immunol 27, 2571.
26. 26. Bezouska K., Yeun C.-T., O'Brien J. et al. (1994) Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 372, 150.
27. 27. Atlan H. & Cohen I.R. (1998) Immune information, self-organization, and meaning. Int Immunol 10, 711.